Xirmadan waxa loo istcimaalaa ogaanshaha aashitada tayada leh ee vitro ee 2019-Novel Coronavirus (2019-nCoV), Hargabka A iyo Hargabka B isla mar ahaantaana shaybaarada neefsashada oo ay ku jiraan suufka oropharyngeal iyo xaakada.Qalabka aasaasiga ah iyo baaritaanka FAM-ku summadan waxaa loogu talagalay in si gaar ah loo ogaado labada hiddo-wadaha ORFlab iyo N ee 2019-nCoV, VIC waxay ku calaamadsan tahay baaritaanka hidda-wadaha RNase P ee aadanaha sida kontoroolka gudaha, ROX waxay ku calaamadsan tahay baaritaanka M hidda-wadaha Hargabka A, CY5 waxay ku calaamadisay baaritaanka hidda-wadaha NS Hargabka B.
| Qaybaha | 50 tijaabo/xirmo |
| Dib-u-celinta falcelinta RT-PCR | 915 μL × 1 tube |
| Isku darka enzyme RT-PCR | 75 μL × 1 tube |
| Xakamaynta togan | 100 μL × 1 tube |
| Xakamaynta xun | 100 μL × 1 tube |
Dareenka: 200 koobi/ml
Gaar ahaan: Wax falcelin ah ma leh SARS-CoV, MERS-CoV, CoV-HKU1, CoV-OC43, CoV-229E, CoV-NL63, Fayraska Parainfluenza, Adenovirus, Human Rhinovirus, Fayraska Isku-xidhka Neefsiga (A), Isku-xidhka Neefsashada Virus (B), Enterovirus A, Staphylococcus Aureus, Streptococcus Pneumonia, Klebsiella Pneumonia.
Saxnimada: CV ≤ 5%.
Nidaamka PCR-waqtiga-dhabta ah:Aehealth Diagenex AL,Molarray MA-6000, ABI 7500, ViiATM7, QuantStudio 7 flex, Roche Lightcycler 480, Agilent Mx3000P/3005P, Rotor-GeneTM6000/Q, Bio-Rad CFX96 taabashadaTM/iQTM5, SLAN-96S/96P